Parenteral Drugs (India) is currently trading at Rs. 29.95, up by 0.85 points or 2.92% from its previous closing of Rs. 29.10 on the BSE.
The scrip opened at Rs. 29.90 and has touched a high and low of Rs. 30.55 and Rs. 29.90 respectively. So far 2351 shares were traded on the counter.
The BSE group 'B ' stock of face value Rs. 10 has touched a 52 week high of Rs. 125.00 on 17-May-2013 and a 52 week low of Rs. 25.65 on 19-Feb-2014.
Last one week high and low of the scrip stood at Rs. 32.40 and Rs. 28.80 respectively. The current market cap of the company is Rs. 89.30 crore.
The promoters holding in the company stood at 73.28 % while Institutions and Non-Institutions held 0.76 % and 25.96 % respectively.
Parenteral Drugs (India) has commenced the production from its newly established plant of Punjab Formulations, a subsidiary of the company, situated at Ahirana village, Hoshiarpur district in state of Punjab. Further, the production activity of previous plant situated at Jalandar in Punjab state has been discontinued.
Established in the year 1983, Parenteral Drugs has dedicated itself to the manufacturing of the best quality vital life saving drug at the lowest possible cost. It is the pioneer company making 400 mg Ciprofloxacin infusion in 200 ml with 5% dextose.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1808.55 |
Dr. Reddys Lab | 1356.05 |
Cipla | 1464.90 |
Lupin | 2154.00 |
Zydus Lifesciences | 972.05 |
View more.. |